We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
+24.07%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+647.83%
AUM
$15.1B
AUM Growth
+$3.18B
Cap. Flow
+$409M
Cap. Flow %
2.7%
Top 10 Hldgs %
24.45%
Holding
1,348
New
61
Increased
400
Reduced
581
Closed
83

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$82.4M
2
AAPL icon
Apple
AAPL
+$69.3M
3
NVDA icon
NVIDIA
NVDA
+$54.6M
4
AMZN icon
Amazon
AMZN
+$54.6M
5
ABBV icon
AbbVie
ABBV
+$53.8M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$80.3M
2
ADSK icon
Autodesk
ADSK
+$34.8M
3
ORCL icon
Oracle
ORCL
+$34.2M
4
JPM icon
JPMorgan Chase
JPM
+$34M
5
AZO icon
AutoZone
AZO
+$29.4M

Sector Composition

Rank Sector Weight
1 Technology 27.25%
2 Healthcare 18.79%
3 Financials 12.56%
4 Consumer Discretionary 11.24%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GHL
1201
DELISTED
Greenhill & Co., Inc.
GHL
$34K ﹤0.01%
3,436
-10,028
-74% -$99K
GGAL icon
1202
Galicia Financial Group
GGAL
$6.83B
$32K ﹤0.01%
3,308
– –
EWT icon
1203
iShares MSCI Taiwan ETF
EWT
$11.6B
$30K ﹤0.01%
758
– –
TEO icon
1204
Telecom Argentina
TEO
$5.91B
$28K ﹤0.01%
3,080
– –
GBT
1205
DELISTED
Global Blood Therapeutics, Inc.
GBT
$27K ﹤0.01%
425
– –
NATI
1206
DELISTED
National Instruments Corp
NATI
$24K ﹤0.01%
+614
New +$23.2K
NTLA icon
1207
Intellia Therapeutics
NTLA
$1.6B
$21K ﹤0.01%
1,020
– –
SGMO
1208
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$21K ﹤0.01%
2,300
– –
ARWR icon
1209
Arrowhead Research
ARWR
$10.9B
$20K ﹤0.01%
+200
New +$7.06K
PRLB icon
1210
Protolabs
PRLB
$1.88B
$19K ﹤0.01%
165
– –
BLFS icon
1211
BioLife Solutions
BLFS
$1.77B
$18K ﹤0.01%
1,100
– –
MNDT
1212
DELISTED
Mandiant, Inc. Common Stock
MNDT
$18K ﹤0.01%
1,500
-1,500
-50% -$17.4K
EXP icon
1213
Eagle Materials
EXP
$5.6B
$16K ﹤0.01%
+231
New +$14.5K
IOVA icon
1214
Iovance Biotherapeutics
IOVA
$4.13B
$16K ﹤0.01%
600
– –
LAZ icon
1215
Lazard
LAZ
$3.74B
$15K ﹤0.01%
+508
New +$13.8K
SPN
1216
DELISTED
Superior Energy Services, Inc.
SPN
$15K ﹤0.01%
13,300
– –
FL
1217
DELISTED
Foot Locker
FL
$13K ﹤0.01%
440
– –
RGNX icon
1218
Regenxbio
RGNX
$539M
$13K ﹤0.01%
360
– –
WAL icon
1219
Western Alliance Bancorporation
WAL
$8.76B
$11K ﹤0.01%
290
-33,237
-99% -$1.16M
MAT icon
1220
Mattel
MAT
$3.83B
$8K ﹤0.01%
845
– –
EVFM
1221
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$8K ﹤0.01%
+179
New +$12.1K
ADVM
1222
DELISTED
Adverum Biotechnologies
ADVM
$2K ﹤0.01%
10
– –
AWI icon
1223
Armstrong World Industries
AWI
$6.72B
$2K ﹤0.01%
29
-605
-95% -$45.9K
APOG icon
1224
Apogee Enterprises
APOG
$772M
– –
-8,450
Closed -$176K
ASC icon
1225
Ardmore Shipping
ASC
$775M
– –
-14,528
Closed -$76K
47 48
49
50 51

Similar funds

Nomura Asset Management
Nomura Asset Management Tokyo, Japan $46.7B AUM 50.59% 1-Year Est. Return
EP
Evelyn Partners London $46.9B AUM
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $45.7B AUM 34.08% 1-Year Est. Return
VCMC
VY Capital Management Company Dubai, United Arab Emirates $47B AUM
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $45.6B AUM 44.74% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
SCP
Soroban Capital Partners New York $47.8B AUM 11.8% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

KBC Group's Q2 2020 Portfolio in Review

As of Q2 2020, KBC Group held 1,348 positions worth $15.1B, up 27% from $11.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

KBC Group's Q2 2020 filing shows 61 new, 400 increased, 581 reduced and 83 closed positions. Its largest new stake was Trade Desk: 211,220 shares worth $8.59M. The largest sale was Allergan plc, an estimated $80.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • KBC Group's largest Q2 2020 buy was Trade Desk: 211,220 shares worth $8.59M.
  • KBC Group added most to Microsoft in Q2 2020, an estimated $82.4M increase.
  • KBC Group's biggest Q2 2020 reduction was Autodesk, cutting an estimated $34.8M.
  • KBC Group fully exited Allergan plc in Q2 2020, selling an estimated $80.3M.
  • KBC Group's ten largest holdings make up 24% of its $15.1B portfolio in Q2 2020.
  • KBC Group opened 61 new positions and closed 83 in Q2 2020.
  • KBC Group's portfolio value rose 27% quarter-over-quarter to $15.1B.

Based on KBC Group's 13F filing for Q2 2020, filed 10 Aug 2020.